Receptor tyrosine kinase function as molecular target in cancer.

受体酪氨酸激酶作为癌症的分子靶标。

• 批准号: nhmrc : 1003908
• 负责人: A/Pr Martin Lackmann
• 金额: $ 27.72万
• 依托单位: Monash University
• 依托单位国家: 澳大利亚
• 项目类别: NHMRC Research Fellowships
• 财政年份: 2011
• 资助国家: 澳大利亚
• 起止时间: 2011-01-01 至 2014-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/receptor-tyrosine-kinase-target-cancer/108981
• 关键词: Receptor; tyrosine; kinase; function; molecular

As molecular cell biologist and protein chemist my motivation for research is to tackle metastatic cancer, one of the principle health burdens of the 21 century. Over the next five years I will lead R&D programs with national and international collaborators that will generate new diagnostic approaches and insights in basic and translational research. These will allow us to develop anti-cancer drugs, which target several of the mechanisms that are active in metastatic cancers.

作为分子细胞生物学家和蛋白质化学家，我的研究动机是解决转移性癌症，这是21世纪主要的健康负担之一。在接下来的五年里，我将领导研发项目，与国内和国际合作者合作，在基础研究和转化研究中产生新的诊断方法和见解。这将使我们能够开发针对转移性癌症中活跃的几种机制的抗癌药物。